Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bateman D. N., Rawlins M. D., Simpson J. M. Extrapyramidal reactions to prochlorperazine and haloperidol in the United Kingdom. Q J Med. 1986 Jun;59(230):549–556. [PubMed] [Google Scholar]
- Bateman D. N., Rawlins M. D., Simpson J. M. Extrapyramidal reactions with metoclopramide. Br Med J (Clin Res Ed) 1985 Oct 5;291(6500):930–932. doi: 10.1136/bmj.291.6500.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Colin Jones D. G., Langman M. J., Lawson D. H., Vessey M. P. Post-marketing surveillance of the safety of cimetidine: twelve-month morbidity report. Q J Med. 1985 Mar;54(215):253–268. [PubMed] [Google Scholar]
- Colin-Jones D. G., Langman M. J., Lawson D. H., Vessey M. P. Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up. Br Med J (Clin Res Ed) 1985 Oct 19;291(6502):1084–1088. doi: 10.1136/bmj.291.6502.1084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. Lancet. 1981 Mar 7;1(8219):541–546. [PubMed] [Google Scholar]
- Goudie B. M., Birnie G. F., Watkinson G., MacSween R. N., Kissen L. H., Cunningham N. E. Jaundice associated with the use of benoxaprofen. Lancet. 1982 Apr 24;1(8278):959–959. doi: 10.1016/s0140-6736(82)91953-5. [DOI] [PubMed] [Google Scholar]
- Hindson C., Daymond T., Diffey B., Lawlor F. Side effects of benoxaprofen. Br Med J (Clin Res Ed) 1982 May 8;284(6326):1368–1369. doi: 10.1136/bmj.284.6326.1368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Incidence of arterial disease among oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. J R Coll Gen Pract. 1983 Feb;33(247):75–82. [PMC free article] [PubMed] [Google Scholar]
- Inman W. H., Rawson N. S. Deafness with enalapril and prescription event monitoring. Lancet. 1987 Apr 11;1(8537):872–872. doi: 10.1016/s0140-6736(87)91664-3. [DOI] [PubMed] [Google Scholar]
- Meirik O., Lund E., Adami H. O., Bergström R., Christoffersen T., Bergsjö P. Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet. 1986 Sep 20;2(8508):650–654. doi: 10.1016/s0140-6736(86)90166-2. [DOI] [PubMed] [Google Scholar]
- Mikulaschek W. M. Long-term safety of benoxaprofen. J Rheumatol Suppl. 1980;6:100–107. [PubMed] [Google Scholar]
- Peden N. R., Cargill J. M., Browning M. C., Saunders J. H., Wormsley K. G. Male sexual dysfunction during treatment with cimetidine. Br Med J. 1979 Mar 10;1(6164):659–659. doi: 10.1136/bmj.1.6164.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pike M. C., Henderson B. E., Krailo M. D., Duke A., Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. doi: 10.1016/s0140-6736(83)90450-6. [DOI] [PubMed] [Google Scholar]
- Rawlins M. D. Postmarketing surveillance of adverse reactions to drugs. Br Med J (Clin Res Ed) 1984 Mar 24;288(6421):879–880. doi: 10.1136/bmj.288.6421.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rowland M. G., Stevenson C. J. Exfoliative dermatitis and practolol. Lancet. 1972 May 20;1(7760):1130–1130. doi: 10.1016/s0140-6736(72)91482-1. [DOI] [PubMed] [Google Scholar]
- Taggart H. M., Alderdice J. M. Fatal cholestatic jaundice in elderly patients taking benoxaprofen. Br Med J (Clin Res Ed) 1982 May 8;284(6326):1372–1372. doi: 10.1136/bmj.284.6326.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Venning G. R. Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays? Br Med J (Clin Res Ed) 1983 Jan 22;286(6361):289–292. doi: 10.1136/bmj.286.6361.289. [DOI] [PMC free article] [PubMed] [Google Scholar]